Public Health

CISAC
Stanford University
Encina Hall, E209
Stanford, CA 94305-6165

0
Senior Fellow at the Freeman Spogli Institute for International Studies
Thomas C. and Joan M. Merigan Professor
Professor of Medicine
Professor of Microbiology and Immunology
1-RSD13_085_0052a-001.jpg MD

David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine, and of Microbiology and Immunology at Stanford University, and Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. He is also Senior Fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford, and served as science co-director at the Center for International Security and Cooperation at Stanford from 2013-2017. He is currently director of a new Biosecurity Initiative at FSI.

Relman was an early pioneer in the modern study of the human indigenous microbiota. Most recently, his work has focused on human microbial community assembly, and community stability and resilience in the face of disturbance. Ecological theory and predictions are tested in clinical studies with multiple approaches for characterizing the human microbiome. Previous work included the development of molecular methods for identifying novel microbial pathogens, and the subsequent identification of several historically important microbial disease agents. One of his papers was selected as “one of the 50 most important publications of the past century” by the American Society for Microbiology.

Dr. Relman received an S.B. (Biology) from MIT, M.D. from Harvard Medical School, and joined the faculty at Stanford in 1994. He served as vice-chair of the NAS Committee that reviewed the science performed as part of the FBI investigation of the 2001 Anthrax Letters, as a member of the National Science Advisory Board on Biosecurity, and as President of the Infectious Diseases Society of America. He is currently a member of the Intelligence Community Studies Board and the Committee on Science, Technology and the Law, both at the National Academies of Science. He has received an NIH Pioneer Award, an NIH Transformative Research Award, and was elected a member of the National Academy of Medicine in 2011.

Stanford Health Policy Affiliate
CV
Paragraphs

Objectives

To analyze sociotechnical issues involved in the process of developing an interoperable commercial Personal Health Record (PHR) in a hospital setting, and to create guidelines for future PHR implementations.

Methods

This qualitative study utilized observational research and semi-structured interviews with 8 members of the hospital team, as gathered over a 28 week period of developing and adapting a vendor-based PHR at Lucile Packard Children’s Hospital at Stanford University. A grounded theory approach was utilized to code and analyze over 100 pages of typewritten field notes and interview transcripts. This grounded analysis allowed themes to surface during the data collection process which were subsequently explored in greater detail in the observations and interviews.

Results

Four major themes emerged: (1) Multidisciplinary teamwork helped team members identify crucial features of the PHR; (2) Divergent goals for the PHR existed even within the hospital team; (3) Differing organizational conceptions of the end-user between the hospital and software company differentially shaped expectations for the final product; (4) Difficulties with coordination and accountability between the hospital and software company caused major delays and expenses and strained the relationship between hospital and software vendor.

Conclusions

Though commercial interoperable PHRs have great potential to improve healthcare, the process of designing and developing such systems is an inherently sociotechnical process with many complex issues and barriers. This paper offers recommendations based on the lessons learned to guide future development of such PHRs.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Applied Clinical Informatics
Authors

Encina Commons Room 180,
615 Crothers Way,
Stanford, CA 94305-6006

(650) 736-0403 (650) 723-1919
0
LCY: Tan Lan Lee Professor
Professor, Health Policy
Professor Pediatrics (General Pediatrics)
jason_wang_profile_2019.jpg MD, PhD

C. Jason Wang, M.D., Ph.D. is a Professor of Pediatrics and Health Policy and director of the Center for Policy, Outcomes, and Prevention at Stanford University.  He received his B.S. from MIT, M.D. from Harvard, and Ph.D. in policy analysis from RAND.  After completing his pediatric residency training at UCSF, he worked in Greater China with McKinsey and Company, during which time he performed multiple studies in the Asian healthcare market. In 2000, he was recruited to serve as the project manager for the Taskforce on Reforming Taiwan's National Health Insurance System. His fellowship training in health services research included the Robert Wood Johnson Clinical Scholars Program and the National Research Service Award Fellowship at UCLA. Prior to coming to Stanford in 2011, he was an Assistant Professor of Pediatrics and Public Health (2006-2010) and Associate Professor (2010-2011) at Boston University and Boston Medical Center. 

Among his accomplishments, he was selected as the student speaker for Harvard Medical School Commencement (1996).  He received the Overseas Chinese Outstanding Achievement Medal (1996), the Robert Wood Johnson Physician Faculty Scholars Career Development Award (2007), the CIMIT Young Clinician Research Award for Transformative Innovation in Healthcare Research (2010), and the NIH Director’s New Innovator Award (2011). He was recently named a “Viewpoints” editor and a regular contributor for the Journal of the American Medical Association (JAMA).  He served as an external reviewer for the 2011 IOM Report “Child and Adolescent Health and Health Care Quality: Measuring What Matters” and as a reviewer for AHRQ study sections.

Dr. Wang has written two bestselling Chinese books published in Taiwan and co-authored an English book “Analysis of Healthcare Interventions that Change Patient Trajectories”.  His essay, "Time is Ripe for Increased U.S.-China Cooperation in Health," was selected as the first-place American essay in the 2003 A. Doak Barnett Memorial Essay Contest sponsored by the National Committee on United States-China Relations.

Currently he is the principal investigator on a number of quality improvement and quality assessment projects funded by the Robert Wood Johnson Foundation, the National Institutes of Health (USA), Health Resources and Services Administration (HRSA), and the Andrew T. Huang Medical Education Promotion Fund (Taiwan).

Dr. Wang’s research interests include: 1) developing tools for assessing and improving the quality of healthcare; 2) facilitating the use of innovative consumer technology in improving quality of care and health outcomes; 3) studying competency-based medical education curriculum, and 4) improving health systems performance.

Director, Center for Policy, Outcomes & Prevention (CPOP)
Co-Director, PCHA-UHA Research & Learning Collaborative
Co-Chair, Mobile Health & Other Technologies, Stanford Center for Population Health Sciences
Co-Director, Academic General Pediatrics Fellowship
-

The production and distribution of counterfeit medications has become a significant global public health issue. Though not as rampant in the United States, the Food and Drug Administration (FDA) has seen a 10 fold increase in the number of cases investigated, particularly a rise in illegally imported and diverted medications entering our legitimate drug supply. In order to curb these illegal activities, California and the federal government have introduced various pieces of legislation to address this. In addition, international entities, State Boards of Pharmacy and the FDA have begun promoting utilization of radio frequency identification technology and other technology to effectively track the medication supply. In a recent California survey, pharmacists felt strongly that the presence of counterfeit medications poses a problem in their pharmacy practice, but they still face several challenges in identifying counterfeit medications, counseling their patients, and forging their role in implementing legislative requirements.

This presentation will aim to provide an introduction to the international and domestic counterfeit drugs situation, discuss possible factors facilitating patient exposure to counterfeit medications, examine potential sources for counterfeit medications in the United States, identifiy federal legislation issues, discuss various forms of technology being used to combat counterfeit medications, and recognize the role of pharmacists and the challenges they face in dealing with counterfeit medications.


Speaker Biography:

Dr. Elaine Law is currently a Clinical Pharmacist specializing in Adult General Surgery at UCSF Medical Center and an Assistant Clinical Professor in the UCSF School of Pharmacy. She received a B.S. in Molecular, Cell and Developmental Biology from UCLA, earned a Doctor in Pharmacy from UCSF School of Pharmacy and completed a General Practice Pharmacy Residency at UCSF Medical Center. She holds a Board Certification in Pharmacotherapy and her research interests include roles pharmacists can play in public health issues including counterfeit medications and pharmacist-based immunization programs. She is an advocate of patient care in underserved areas and reaches out regularly to the Tenderloin communities and elderly populations of San Francisco through pharmacy health outreach programs.

Reuben W. Hills Conference Room

Elaine Law Assistant Clinical Professor Speaker UCSF School of Pharmacy
Seminars

The large-scale industrial accident at the Fukushima-Daiichi Nuclear Power Plant was the culmination of three inter-related factors: external natural hazard assessment and site preparation, the utility’s approach to risk management, and the fundamental reactor design.

The reactor accident was initiated by a magnitude 9 earthquake followed by an even more damaging tsunami. However, it was the inability to remove the decay heat in the reactor core that led to core meltdown and radioactive release.

A review of the timeline of the major Fukushima accident sequences: The plant first experienced a station blackout (i.e. loss of all offsite and onsite power) due to flooding of backup critical emergency cooling equipment. The lack of an ultimate heat sink led to the fuel overheating. Subsequently, the generation of hydrogen through steam oxidation of of the fuel cladding led to chemical explosions causing significant structural damage.

The focus of this talk (presentation slides below) is on the engineering aspects of the reactor accident and the prospects for local environmental recovery. Radionuclide measurements in space and time provide important evidence for the exact evolution of fuel damage leading to partial core melting in multiple units. A review of the spent nuclear fuel pools is given where isotopic water composition and visual inspection images provide important evidence for the condition of the spent nuclear fuel.

While it will be several months to a year before we will be in a position to learn most of the lessons from this tragdy, several conclusions about defensive design, mitigation actions, and emergency response have been drawn by international organizations.

While the public health impact appears to have been low, the economic and nearby environmental consequences are severe, There is no doubt that land restoration will take over a decade and perhaps much longer. A review is given of actions taken by the Japanese government for land recovery in areas such as decontaminating top soil and local farmland as well as highly radioactive water used during ‘feed and bleed’ cooling of the core.

Edward Blandford Panelist
Seminars
-

In spite of the economic advances and increases in GDP since the collapse of communism, Russia suffers from a range of dismal public health outcomes reminiscent of a much poorer country. This study seeks to understand what role political factors play in the country's high adult mortality rate and declining life expectancy by mining World Bank and World Health Organization data and examining how Russians access healthcare services and information.

Walter P. Falcon Lounge

FSI
Stanford University
Encina Hall C140
Stanford, CA 94305-6055

(650) 736-1820 (650) 724-2996
0
Satre Family Senior Fellow, Freeman Spogli Institute for International Studies
kathryn_stoner_1_2022_v2.jpg MA, PhD

Kathryn Stoner is the Mosbacher Director of the Center on Democracy, Development, and the Rule of Law (CDDRL), and a Senior Fellow at CDDRL and the Center on International Security and Cooperation at FSI. From 2017 to 2021, she served as FSI's Deputy Director. She is Professor of Political Science (by courtesy) at Stanford and she teaches in the Department of Political Science, and in the Program on International Relations, as well as in the Ford Dorsey Master's in International Policy Program. She is also a Senior Fellow (by courtesy) at the Hoover Institution.

Prior to coming to Stanford in 2004, she was on the faculty at Princeton University for nine years, jointly appointed to the Department of Politics and the Princeton School for International and Public Affairs (formerly the Woodrow Wilson School). At Princeton she received the Ralph O. Glendinning Preceptorship awarded to outstanding junior faculty. She also served as a Visiting Associate Professor of Political Science at Columbia University, and an Assistant Professor of Political Science at McGill University. She has held fellowships at Harvard University as well as the Woodrow Wilson Center in Washington, DC. 

In addition to many articles and book chapters on contemporary Russia, she is the author or co-editor of six books: "Transitions to Democracy: A Comparative Perspective," written and edited with Michael A. McFaul (Johns Hopkins 2013);  "Autocracy and Democracy in the Post-Communist World," co-edited with Valerie Bunce and Michael A. McFaul (Cambridge, 2010);  "Resisting the State: Reform and Retrenchment in Post-Soviet Russia" (Cambridge, 2006); "After the Collapse of Communism: Comparative Lessons of Transitions" (Cambridge, 2004), coedited with Michael McFaul; and "Local Heroes: The Political Economy of Russian Regional" Governance (Princeton, 1997); and "Russia Resurrected: Its Power and Purpose in a New Global Order" (Oxford University Press, 2021).

She received a BA (1988) and MA (1989) in Political Science from the University of Toronto, and a PhD in Government from Harvard University (1995). In 2016 she was awarded an honorary doctorate from Iliad State University, Tbilisi, Republic of Georgia.

Download full-resolution headshot; photo credit: Rod Searcey.

Mosbacher Director, Center on Democracy, Development and the Rule of Law
Professor of Political Science (by courtesy), Stanford University
Senior Fellow (by courtesy), Hoover Institution
CV
Date Label
Kathryn Stoner-Weiss FSI senior fellow Speaker
Rajaie Batniji Postdoctoral fellow, department of medicine, Stanford University Speaker
Seminars
News Type
News
Date
Paragraphs
What influence might graphic warning labels have on cigarette sales? Matthew Kohrman is studying that question with experimental methods in Southwest China. Kohrman’s research is generating much-needed data in support of the expansion of China’s warning label system. Among the countries increasingly adopting graphic labels, the United States will require visual warnings on all cigarette packages by next fall.

Stanford Cancer Center News: Smoking cessation in a land of two trillion cigarettes
Hero Image
PikkelRyanNEWSFEED
Packages of cigarettes for sale in China.
Ryan Pikkel
All News button
1
Paragraphs

First page of the article:

Reports of sexual violence during the ongoing unrest in Libya have captured headlines across the world. Libyan leader Muammar al-Qaddafi's forces, some have alleged, were given Viagra to facilitate their rape of hundreds, if not thousands, of victims. Recently, Luis Moreno-Ocampo, the chief prosecutor at the International Criminal Court, and U.S. Secretary of State Hillary Clinton both expressed outrage at what was apparently a purposeful campaign. Yet recent reports by the U.N. and by advocacy groups shed doubt on these claims. Amnesty International, for example, has been unable to locate a single rape victim, or even anyone who knows a victim.

As the veracity of stories about sexual violence in Libya came into question, the American Journal of Public Health published a study estimating that the prevalence of rape in the Democratic Republic of the Congo was far worse than previously documented. The article estimated that between 2006 and 2007 more than 400,000 women between the ages of 15 and 49 were raped during the war there -- 26 times the U.N.'s official count.

So what are we to make of these two cases -- a possible exaggeration of rape in Libya and a gross underestimation of it in the DRC? Wartime sexual violence has rightly been called a hidden epidemic; in truth, we know very little about its actual magnitude and impact. Reports of rape are increasingly common in countries wracked by conflict, such as Colombia, the DRC, East Timor, Côte d'Ivoire, Libya, and Sudan, but no one knows what the relationship is between increased reports and increased rape. Even in peacetime, sexual violence is severely and unevenly underreported. Beyond prevalence, patterns of where, when, and by whom rape is committed -- not to mention why it is committed -- are even less clear. War exponentially worsens these problems. As a result, estimates of rape in prominent conflicts are often unreliable.


All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Foreign Affairs
Authors
Subscribe to Public Health